Supply of Epizootic Haemorrhagic Disease Serotype 8 (EHDV-8) Vaccine

The Authority is exploring the status of EHDV-8 products that have the potential to be available for use in 2025 (either as an authorised product or emergency use under Schedule 4) to help to inform our control strategy for EHD and consideration as to whether government intervention is required to facilitate access to the UK livestock sector of any product that may become available. <br/><br/>EHDV-8 was identified in for the first time in southern Europe in November 2022. It is not currently present in the UK. While there is no evidence of circulation currently, we expect a continued threat of incursion as EHD could also spread to the UK if infected live animals, or their germinal products, are imported from countries where EHD is circulating. It is widely accepted that access to vaccine will be an important tool to protect the health and welfare of susceptible species and for livestock keepers for whom trade in live animals is important. <br/><br/>The Authority is interested in:<br/> the details of any suitable products currently under development <br/> the extent of developments<br/> safety and efficacy testing, timelines for submitting applications for marketing authorisation to the VMD.<br/> the type of technology used to develop the vaccine, production capacity (current and forecast)<br/> whether the specific vaccine is authorised elsewhere in the world or based on an already authorised EHDV vaccine. <br/> whether products under development will be monovalent or multivalent and which serotypes would be included in multivalent products. <br/> We are also interested to understand the likely wholesale and retail costs of any product likely to be available. Additional information: This Prior Information Notice is not a call for competition. It should be noted that this PIN invites individuals and organisations to express an interest only, and although it is not part of a formal pre-qualification process it may be used to inform discussions with vaccine suppliers. <br/><br/>You will need to express your interest in any potential future tender opportunity once/if a contract notice is published in Find a Tender and on Contract Finder. It should be noted that this PIN invites individuals and organisations to express an interest only. Those wishing to provide information requested here should contact Louise Moizer ([email protected]), by the end of March 2025 to inform our strategy development.